Related Experiment Video

Updated: Oct 11, 2025

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug
07:50

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug

Published on: June 4, 2021

2.9K

EFFECTIVENESS OF DEEP VENOUS THROMBOSIS PREVENTION IN TOTAL HIP ARTHROPLASTY

Victor Martins Manfredi1, Matheus Bittencourt Machado1, Nícolas Giorgini Barbato1

  • 1Ifor Hospital, Institute of Fractures, Orthopedics and Rehabilitation, São Bernardo do Campo, SP, Brazil.

Acta Ortopedica Brasileira
|December 1, 2021
PubMed

Insights

This study demonstrates the high efficacy of a Deep Venous Thrombosis (DVT) prophylaxis protocol in total hip arthroplasty (THA) patients, with only a 1.09% complication rate. The protocol is essential for preventing DVT after THA.

Area of Science:

  • Orthopedic Surgery
  • Vascular Medicine
  • Thromboprophylaxis

Background:

  • Deep Venous Thrombosis (DVT) is a significant risk following total hip arthroplasty (THA).
  • Effective prophylaxis protocols are crucial for patient safety and surgical outcomes.

Purpose of the Study:

  • To evaluate the efficacy of a specific DVT prophylaxis protocol in THA patients.
  • To compare DVT rates between primary and revision THA surgeries.

Main Methods:

  • Retrospective study of 92 patients (110 hips) operated between 2012-2018.
  • Implementation of a DVT prophylaxis protocol including low molecular weight heparin, compression devices, and early ambulation.
  • DVT detection via clinical evaluation and imaging (radiographs, ultrasound, Doppler), and laboratory tests.

Main Results:

  • The DVT prophylaxis protocol demonstrated high efficacy, with only one case (1.09%) of DVT observed.
  • The study suggests a low incidence of DVT when the protocol is rigorously followed.

Conclusions:

  • Thromboprophylaxis for DVT is indispensable in THA patients.
  • The observed low DVT rate (1.09%) underscores the effectiveness of the implemented protocol.
Abstract

Keywords:
Arthroplasty Replacement HipCombined Modality TherapyDiagnosisPrimary PreventionVenous Thrombosis

More Related Videos

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis06:45

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis

Published on: February 10, 2023

14.6K
A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis10:26

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis

Published on: June 2, 2015

17.5K

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
55
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
43
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
72
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
64
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
48
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.4K